Announcements Trials
Browse Landscape

Phase

Phase NA 45Phase 2 10Phase 4 7Phase 3 5Phase 1 4Phase 1/2 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Neoplasms 2009Carcinoma, Non-Small-Cell Lung 1222Breast Neoplasms 1214Leukemia, Myeloid, Acute 965Neoplasm Metastasis 900Melanoma 777Colorectal Neoplasms 749Lymphoma 725Multiple Myeloma 723Ovarian Neoplasms 673Pancreatic Neoplasms 664Prostatic Neoplasms 657Lymphoma, Non-Hodgkin 657Recurrence 636Precursor Cell Lymphoblastic Leukemia-Lymphoma 583Lung Neoplasms 559Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 527Leukemia 485Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 418Brain Neoplasms 413Squamous Cell Carcinoma of Head and Neck 388Stomach Neoplasms 386Carcinoma, Renal Cell 384Myelodysplastic Syndromes 381Carcinoma, Hepatocellular 367Advanced Solid Tumors 356Lymphoma, Mantle-Cell 345Glioma 342

Interventions

relacorilant 1pembrolizumab 1Vitamin D 1Preventive Health Services 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Hypertension × Clear all
NCT04373265 2024-02-23

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

Corcept Therapeutics

Phase 1 Completed
15 enrolled
Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, Diabetes Mellitus, Type 2, Endocrine System Diseases, Hyperglycemia, Hypertension, Pathologic Processes, Glucose Intolerance, Adrenocortical Carcinoma

NCT00585637 2015-04-01

Vitamin D for Chemoprevention

Dana-Farber Cancer Institute

Phase 1 Completed
328 enrolled 11 charts
GastrointestinalGenitourinary

Gastrointestinal Neoplasms, Hypertension, Neoplasms, Prostatic Neoplasms

NCT01599143 2012-05-15

mbsr

North York General Hospital

Phase 1 Completed
135 enrolled

Anxiety Disorders, Back Pain, Diabetes Mellitus, Fibromyalgia, Hypertension, Migraine Disorders, Neoplasms, Somatoform Disorders

NCT00242645 2010-08-25

Computer-Assisted Cancer Risk Behavior Counseling

Thomas Jefferson University

Phase 1 Terminated
200 enrolled

Diabetes Mellitus, Health Education, Hypertension, Health Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡